About
Axial partners with great founders and inventors. We invest in early-stage life sciences…
Articles by Joshua
-
Analysis of exciting Stanford life sciences inventors and their inventions
Analysis of exciting Stanford life sciences inventors and their inventions
By Joshua Elkington
-
Analysis of exciting UCSF life sciences inventors and their inventions
Analysis of exciting UCSF life sciences inventors and their inventions
By Joshua Elkington
-
Analysis of exciting Berkeley life sciences inventors and their inventions
Analysis of exciting Berkeley life sciences inventors and their inventions
By Joshua Elkington
Activity
-
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins https://lnkd.in/gDfH5drY
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins https://lnkd.in/gDfH5drY
Liked by Joshua Elkington
-
Super proud for Color to work on this program Karen Knudsen and the American Cancer Society team to provide free colorectal cancer screening in…
Super proud for Color to work on this program Karen Knudsen and the American Cancer Society team to provide free colorectal cancer screening in…
Liked by Joshua Elkington
-
Friends: I was humbled and exhilarated to hike earlier this week on the Timmerman Traverse for Life Science Cares. I want to thank every individual…
Friends: I was humbled and exhilarated to hike earlier this week on the Timmerman Traverse for Life Science Cares. I want to thank every individual…
Liked by Joshua Elkington
Education
-
Harvard University
-
Evolutionary analysis of aging and the stress response. Senior Thesis: Genetic Requirements for Environmental RNA Interference. Biodevices, BOSS Lab, HAPIE (board games), HFAC, Harvard Bitcoin (now at HBS), Ruvkun Lab, Chess, Student Advisory Board of Science, Harvard Biotechnology Club (was HBE).
-
-
Development and discovery of CRISPR systems. Tjian and Doudna Labs. Gates and NIH fellowships. Evexia BioFund. Indie Bio advisor. Yosemite Conservancy.
Volunteer Experience
-
-
Volunteer
Hathaway Ranch & Oil Museum
Arts and Culture
-
-
-
More activity by Joshua
-
Latch Registry provides error-validated metadata capture for wet lab scientists and bioinformaticians to create a single source of truth for their…
Latch Registry provides error-validated metadata capture for wet lab scientists and bioinformaticians to create a single source of truth for their…
Liked by Joshua Elkington
-
Check out our new walkthrough on multi-chain protein optimization at OpenProtein.AI!
Check out our new walkthrough on multi-chain protein optimization at OpenProtein.AI!
Liked by Joshua Elkington
-
Today in Cell, we report our evidence for a covalent linkage between small RNAs and N-glycans via acp3U. Made possible due to the dedicated work of…
Today in Cell, we report our evidence for a covalent linkage between small RNAs and N-glycans via acp3U. Made possible due to the dedicated work of…
Liked by Joshua Elkington
-
So excited to announce that Parallel's Virtual Spa Days are now available to add to your workplace wellness programs!! 😊 If you're interested, DM…
So excited to announce that Parallel's Virtual Spa Days are now available to add to your workplace wellness programs!! 😊 If you're interested, DM…
Liked by Joshua Elkington
-
Discovery of a new class of integrin antibodies for fibrosis https://lnkd.in/gm5XVGKu
Discovery of a new class of integrin antibodies for fibrosis https://lnkd.in/gm5XVGKu
Liked by Joshua Elkington
-
At Orca Bio, we’re on a mission to transform the lives of patients by developing a pipeline of high-precision cell therapies aimed at expanding…
At Orca Bio, we’re on a mission to transform the lives of patients by developing a pipeline of high-precision cell therapies aimed at expanding…
Liked by Joshua Elkington
-
Introducing the 😱 OMG dataset and 🤖 gLM2! OMG is a massive Open MetaGenomic corpus totaling 3.1Tbp of data and 3.3B proteins. We train gLM2, the…
Introducing the 😱 OMG dataset and 🤖 gLM2! OMG is a massive Open MetaGenomic corpus totaling 3.1Tbp of data and 3.3B proteins. We train gLM2, the…
Liked by Joshua Elkington
-
Less than 5 days to go for our protein design competition at Adaptyv Bio! We just updated the competition page with a virtual leaderboard for the…
Less than 5 days to go for our protein design competition at Adaptyv Bio! We just updated the competition page with a virtual leaderboard for the…
Liked by Joshua Elkington
-
My colleague Adam Piasecki and just posted a summary of our work in next-generation weather data and prediction. It's a remarkable time of…
My colleague Adam Piasecki and just posted a summary of our work in next-generation weather data and prediction. It's a remarkable time of…
Liked by Joshua Elkington
-
Having a hard time with #CRISPR HDR? Your cells might be fighting against you! TREX1 nuclease, highly expressed in some cells, eats up HDR donor…
Having a hard time with #CRISPR HDR? Your cells might be fighting against you! TREX1 nuclease, highly expressed in some cells, eats up HDR donor…
Liked by Joshua Elkington
-
In a world of overly anthropomorphised #robots its great to be reminded as to the characteristics that actually will make them useful and…
In a world of overly anthropomorphised #robots its great to be reminded as to the characteristics that actually will make them useful and…
Liked by Joshua Elkington
-
I'm super proud that, this year, we've got two posters to present at ACS! Well done team!
I'm super proud that, this year, we've got two posters to present at ACS! Well done team!
Liked by Joshua Elkington
-
Not many know this, but one of our main inspirations behind starting Potion AI was a trip I made to South Korea 🇰🇷 years ago. During my stay, I…
Not many know this, but one of our main inspirations behind starting Potion AI was a trip I made to South Korea 🇰🇷 years ago. During my stay, I…
Liked by Joshua Elkington
-
Another Teneobio asset enters phase 3! TNB-486 (now AZD0486) is a low CD3 affinity TCE targeting CD19 and entering phase 3 as a combination with…
Another Teneobio asset enters phase 3! TNB-486 (now AZD0486) is a low CD3 affinity TCE targeting CD19 and entering phase 3 as a combination with…
Liked by Joshua Elkington
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Joshua Elkington
-
Joshua Elkington
-
Joshua Elkington
-
Joshua Elkington
-- Ambitious, Creative and Experienced individual. Level 4 Business, food and health and safety in hospital qualification holder.
-
Joshua Elkington
Realtor @ Lifestyle Realty Inc./ B.D.O for Alta Commercial Capital/Investor/Owner of Point to Point Lawn Care SLC/Contractor Connection for anything home related.
12 others named Joshua Elkington are on LinkedIn
See others named Joshua Elkington